Molecular Mechanisms of Tumor Cell Resistance to Chemotherapy - Targeted Therapies to Reverse Resistance (Hardcover, 2013 ed.)


This volume gives the latest developments in on the mechanisms of cancer cell resistance to apoptotic stimuli, which eventually result in cancer progression and metastasis. One of the main challenges in cancer research is to develop new therapies to combat resistant tumors. The development of new effective therapies will be dependent on delineating the biochemical, molecular, and genetic mechanisms that regulate tumor cell resistance to cytotoxic drug-induced apoptosis. These mechanisms should reveal gene products that directly regulate resistance in order to develop new drugs that target these resistance factors and such new drugs may either be selective or common to various cancers. If successful, new drugs may not be toxic and may be used effectively in combination with subtoxic conventional drugs to achieve synergy and to reverse tumor cell resistance. The research developments presented in this book can be translated to produce better clinical responses to resistant tumors.

R4,934
List Price R5,123

Or split into 4x interest-free payments of 25% on orders over R50
Learn more

Discovery Miles49340
Mobicred@R462pm x 12* Mobicred Info
Free Delivery
Delivery AdviceShips in 12 - 17 working days



Product Description

This volume gives the latest developments in on the mechanisms of cancer cell resistance to apoptotic stimuli, which eventually result in cancer progression and metastasis. One of the main challenges in cancer research is to develop new therapies to combat resistant tumors. The development of new effective therapies will be dependent on delineating the biochemical, molecular, and genetic mechanisms that regulate tumor cell resistance to cytotoxic drug-induced apoptosis. These mechanisms should reveal gene products that directly regulate resistance in order to develop new drugs that target these resistance factors and such new drugs may either be selective or common to various cancers. If successful, new drugs may not be toxic and may be used effectively in combination with subtoxic conventional drugs to achieve synergy and to reverse tumor cell resistance. The research developments presented in this book can be translated to produce better clinical responses to resistant tumors.

Customer Reviews

No reviews or ratings yet - be the first to create one!

Product Details

General

Imprint

Springer-Verlag New York

Country of origin

United States

Series

Resistance to Targeted Anti-Cancer Therapeutics, 1

Release date

April 2013

Availability

Expected to ship within 12 - 17 working days

First published

2013

Editors

Dimensions

235 x 155 x 20mm (L x W x T)

Format

Hardcover

Pages

260

Edition

2013 ed.

ISBN-13

978-1-4614-7069-4

Barcode

9781461470694

Categories

LSN

1-4614-7069-2



Trending On Loot